Drugs / Epoetin Alfa-BioManguinhos
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01184495 | Apr → Dec 2008 | — | Hospital de Clinicas de Porto Alegre | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epoetin Alfa-BioManguinhos | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01184495 ↗ |
| Route | Subcutaneous | “Subcutaneous administration of EPO-BioManguinhos” NCT01184495 ↗ |